Biosimilar and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Overall Market Size
2.1 Global Biosimilar Market Size: 2021 VS 2028
2.2 Global Biosimilar Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Players in Global Market
3.2 Top Global Biosimilar Companies Ranked by Revenue
3.3 Global Biosimilar Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilar Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biosimilar Market Size Markets, 2021 & 2028
4.1.2 Biosimilar Monoclonal Antibodies
4.1.3 Biosimilar Insulin
4.1.4 Others
4.2 By Type - Global Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Immunological Diseases
5.1.4 Diabetes
5.1.5 Others
5.2 By Application - Global Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Revenue, 2017-2022
5.2.2 By Application - Global Biosimilar Revenue, 2023-2028
5.2.3 By Application - Global Biosimilar Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biosimilar Revenue, 2017-2028
6.3.2 US Biosimilar Market Size, 2017-2028
6.3.3 Canada Biosimilar Market Size, 2017-2028
6.3.4 Mexico Biosimilar Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biosimilar Revenue, 2017-2028
6.4.2 Germany Biosimilar Market Size, 2017-2028
6.4.3 France Biosimilar Market Size, 2017-2028
6.4.4 U.K. Biosimilar Market Size, 2017-2028
6.4.5 Italy Biosimilar Market Size, 2017-2028
6.4.6 Russia Biosimilar Market Size, 2017-2028
6.4.7 Nordic Countries Biosimilar Market Size, 2017-2028
6.4.8 Benelux Biosimilar Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biosimilar Revenue, 2017-2028
6.5.2 China Biosimilar Market Size, 2017-2028
6.5.3 Japan Biosimilar Market Size, 2017-2028
6.5.4 South Korea Biosimilar Market Size, 2017-2028
6.5.5 Southeast Asia Biosimilar Market Size, 2017-2028
6.5.6 India Biosimilar Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biosimilar Revenue, 2017-2028
6.6.2 Brazil Biosimilar Market Size, 2017-2028
6.6.3 Argentina Biosimilar Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Revenue, 2017-2028
6.7.2 Turkey Biosimilar Market Size, 2017-2028
6.7.3 Israel Biosimilar Market Size, 2017-2028
6.7.4 Saudi Arabia Biosimilar Market Size, 2017-2028
6.7.5 UAE Biosimilar Market Size, 2017-2028
7 Players Profiles
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Corporate Summary
7.1.2 Qilu Pharmaceutical Business Overview
7.1.3 Qilu Pharmaceutical Biosimilar Major Product Offerings
7.1.4 Qilu Pharmaceutical Biosimilar Revenue in Global Market (2017-2022)
7.1.5 Qilu Pharmaceutical Key News
7.2 Bio-Thera
7.2.1 Bio-Thera Corporate Summary
7.2.2 Bio-Thera Business Overview
7.2.3 Bio-Thera Biosimilar Major Product Offerings
7.2.4 Bio-Thera Biosimilar Revenue in Global Market (2017-2022)
7.2.5 Bio-Thera Key News
7.3 Zhejiang Hisun
7.3.1 Zhejiang Hisun Corporate Summary
7.3.2 Zhejiang Hisun Business Overview
7.3.3 Zhejiang Hisun Biosimilar Major Product Offerings
7.3.4 Zhejiang Hisun Biosimilar Revenue in Global Market (2017-2022)
7.3.5 Zhejiang Hisun Key News
7.4 Shanghai Henlius
7.4.1 Shanghai Henlius Corporate Summary
7.4.2 Shanghai Henlius Business Overview
7.4.3 Shanghai Henlius Biosimilar Major Product Offerings
7.4.4 Shanghai Henlius Biosimilar Revenue in Global Market (2017-2022)
7.4.5 Shanghai Henlius Key News
7.5 Innovent Biologics
7.5.1 Innovent Biologics Corporate Summary
7.5.2 Innovent Biologics Business Overview
7.5.3 Innovent Biologics Biosimilar Major Product Offerings
7.5.4 Innovent Biologics Biosimilar Revenue in Global Market (2017-2022)
7.5.5 Innovent Biologics Key News
7.6 Jiangsu Hengrui
7.6.1 Jiangsu Hengrui Corporate Summary
7.6.2 Jiangsu Hengrui Business Overview
7.6.3 Jiangsu Hengrui Biosimilar Major Product Offerings
7.6.4 Jiangsu Hengrui Biosimilar Revenue in Global Market (2017-2022)
7.6.5 Jiangsu Hengrui Key News
7.7 Gan&Lee
7.7.1 Gan&Lee Corporate Summary
7.7.2 Gan&Lee Business Overview
7.7.3 Gan&Lee Biosimilar Major Product Offerings
7.7.4 Gan&Lee Biosimilar Revenue in Global Market (2017-2022)
7.7.5 Gan&Lee Key News
7.8 Tonghua Dongbao
7.8.1 Tonghua Dongbao Corporate Summary
7.8.2 Tonghua Dongbao Business Overview
7.8.3 Tonghua Dongbao Biosimilar Major Product Offerings
7.8.4 Tonghua Dongbao Biosimilar Revenue in Global Market (2017-2022)
7.8.5 Tonghua Dongbao Key News
7.9 United Laboratory
7.9.1 United Laboratory Corporate Summary
7.9.2 United Laboratory Business Overview
7.9.3 United Laboratory Biosimilar Major Product Offerings
7.9.4 United Laboratory Biosimilar Revenue in Global Market (2017-2022)
7.9.5 United Laboratory Key News
7.10 3SBIO
7.10.1 3SBIO Corporate Summary
7.10.2 3SBIO Business Overview
7.10.3 3SBIO Biosimilar Major Product Offerings
7.10.4 3SBIO Biosimilar Revenue in Global Market (2017-2022)
7.10.5 3SBIO Key News
7.11 Luye Pharma
7.11.1 Luye Pharma Corporate Summary
7.11.2 Luye Pharma Business Overview
7.11.3 Luye Pharma Biosimilar Major Product Offerings
7.11.4 Luye Pharma Biosimilar Revenue in Global Market (2017-2022)
7.11.5 Luye Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biosimilar Market Opportunities & Trends in Global Market
Table 2. Biosimilar Market Drivers in Global Market
Table 3. Biosimilar Market Restraints in Global Market
Table 4. Key Players of Biosimilar in Global Market
Table 5. Top Biosimilar Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilar Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilar Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilar Product Type
Table 9. List of Global Tier 1 Biosimilar Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilar Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilar Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilar Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilar Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilar Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilar Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilar Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilar Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilar Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilar Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilar Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilar Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilar Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilar Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilar Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilar Revenue, (US$, Mn), 2023-2028
Table 30. Qilu Pharmaceutical Corporate Summary
Table 31. Qilu Pharmaceutical Biosimilar Product Offerings
Table 32. Qilu Pharmaceutical Biosimilar Revenue (US$, Mn), (2017-2022)
Table 33. Bio-Thera Corporate Summary
Table 34. Bio-Thera Biosimilar Product Offerings
Table 35. Bio-Thera Biosimilar Revenue (US$, Mn), (2017-2022)
Table 36. Zhejiang Hisun Corporate Summary
Table 37. Zhejiang Hisun Biosimilar Product Offerings
Table 38. Zhejiang Hisun Biosimilar Revenue (US$, Mn), (2017-2022)
Table 39. Shanghai Henlius Corporate Summary
Table 40. Shanghai Henlius Biosimilar Product Offerings
Table 41. Shanghai Henlius Biosimilar Revenue (US$, Mn), (2017-2022)
Table 42. Innovent Biologics Corporate Summary
Table 43. Innovent Biologics Biosimilar Product Offerings
Table 44. Innovent Biologics Biosimilar Revenue (US$, Mn), (2017-2022)
Table 45. Jiangsu Hengrui Corporate Summary
Table 46. Jiangsu Hengrui Biosimilar Product Offerings
Table 47. Jiangsu Hengrui Biosimilar Revenue (US$, Mn), (2017-2022)
Table 48. Gan&Lee Corporate Summary
Table 49. Gan&Lee Biosimilar Product Offerings
Table 50. Gan&Lee Biosimilar Revenue (US$, Mn), (2017-2022)
Table 51. Tonghua Dongbao Corporate Summary
Table 52. Tonghua Dongbao Biosimilar Product Offerings
Table 53. Tonghua Dongbao Biosimilar Revenue (US$, Mn), (2017-2022)
Table 54. United Laboratory Corporate Summary
Table 55. United Laboratory Biosimilar Product Offerings
Table 56. United Laboratory Biosimilar Revenue (US$, Mn), (2017-2022)
Table 57. 3SBIO Corporate Summary
Table 58. 3SBIO Biosimilar Product Offerings
Table 59. 3SBIO Biosimilar Revenue (US$, Mn), (2017-2022)
Table 60. Luye Pharma Corporate Summary
Table 61. Luye Pharma Biosimilar Product Offerings
Table 62. Luye Pharma Biosimilar Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biosimilar Segment by Type in 2021
Figure 2. Biosimilar Segment by Application in 2021
Figure 3. Global Biosimilar Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilar Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar Revenue in 2021
Figure 8. By Type - Global Biosimilar Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilar Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilar Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilar Revenue Market Share, 2017-2028
Figure 12. US Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilar Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilar Revenue Market Share, 2017-2028
Figure 24. China Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilar Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilar Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 37. Qilu Pharmaceutical Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bio-Thera Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zhejiang Hisun Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Shanghai Henlius Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Innovent Biologics Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Jiangsu Hengrui Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gan&Lee Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Tonghua Dongbao Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. United Laboratory Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. 3SBIO Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Luye Pharma Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)